Humana Shares Jump 11.5% After 2027 Medicare Advantage Star Ratings Improve

What happened

Humana Inc. (ticker HUM) announced that 95% of its Medicare Advantage enrollees will be covered by plans with higher Medicare Advantage star ratings for 2027, following an improvement in those quality scores, according to Quartz.

The Wall Street Journal reported that the shares jumped after the insurer received sharply improved scores on the bonus-generating quality ratings. Bloomberg reported that the improved ratings will boost future revenue. Humana is a health insurer whose business is concentrated in Medicare Advantage, the privately run version of the federal Medicare program for people 65 and older.

The stock closed at $431.80 on October 9, 2026, up 11.54% from the prior close of $387.12, according to the price data. Volume was 4,616,855 shares against an average of 1,253,738, or 3.68 times normal. Investopedia reported shares were up more than 15% to $446 in early trading, their highest level since early 2024, and that Humana was the best performer in the S&P 500 that day. The Globe and Mail, citing StockStory, reported that Robert W. Baird upgraded Humana to Outperform.

A Facebook post attributed to Investopedia claimed Humana fell about 3.4% on the news. That claim contradicts the price data and the other reports, and is not treated here as accurate.

What Medicare Advantage star ratings are

Medicare Advantage is a system in which private insurers such as Humana administer Medicare benefits and are paid by the federal government per enrollee. Star ratings are the government's quality scorecard for those plans, on a scale of one to five stars, based on measures such as customer service, preventive screenings and management of chronic conditions.

The ratings matter financially because plans rated four stars or higher receive bonus payments on top of their normal government reimbursement. Those bonuses are the mechanism connecting a quality score to revenue: a higher rating means more money per member, and a lower rating means less, with the effect lasting for the payment year the rating applies to.

Humana's announcement concerns the 2027 ratings. In this case, the company said the share of its Medicare Advantage enrollees in higher-rated plans will be 95%, a figure that describes how much of its membership sits in plans above the bonus threshold.

Why the stock moved

The price and volume data show an 11.5% one-day gain on 3.68 times average volume. That combination indicates the news changed a large number of investors' estimates at once rather than drawing routine trading attention. The reports from the Journal and Bloomberg link the move directly to the ratings and the revenue boost they imply.

The filing and coverage do not specify the prior rating mix or the exact percentage of enrollees affected by the change, so the size of the revenue effect cannot be quantified from these sources. What is established is the direction: higher-rated plans receive bonus payments, and 95% of Humana's Medicare Advantage enrollees will be in those plans for 2027.

What this means

Star ratings are usually published each fall for the following plan year, so the 2027 scores announced in October 2026 determine Humana's bonus payments through 2027. That makes the announcement a forward-looking input to revenue rather than a current-quarter number.

For a company like Humana, whose business is heavily weighted toward Medicare Advantage, the ratings function like a renewal on a large share of its revenue: a drop would reduce per-member payments, and an improvement increases them. The 95% figure is the key number in the announcement because it indicates how much of the company's membership will sit above the bonus threshold.

The trading reaction reflects that linkage. The Investopedia comparison to early 2024 and the S&P 500 leaderboard placement describe the market's response on the day; they do not constitute a forecast of where the stock goes from here.